Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

0(0%)

Results Posted

88%(7 trials)

Phase Distribution

Ph phase_4

22%

Ph phase_2

22%

Ph not_applicable

22%

Ph phase_3

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 2Efficacy & side effects

2(22.2%)

Phase 3Large-scale testing

3(33.3%)

Phase 4Post-market surveillance

2(22.2%)

N/ANon-phased studies

2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(1)

Detailed Status

Completed8

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (22.2%)

Phase 33 (33.3%)

Phase 42 (22.2%)

N/A2 (22.2%)

Trials by Status

withdrawn111%

completed889%

Recent Activity

0 active trials

Showing 5 of 9

completedphase_3

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

NCT00894556

completedphase_3

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

NCT01001234

completedphase_3

Clinical Trials (9)

Showing 9 of 9 trials

NCT00894556Phase 3

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

Completed

NCT01001234Phase 3

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

Completed

NCT03896009Phase 3

Maximizing Outcomes in Treating Acute Migraine

Completed

NCT02447991Phase 2

Rizatriptan for Episodic Dizziness in Vestibular Migraine

Completed

NCT00246337Phase 2

A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)

Completed

NCT01306266Not Applicable

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops

Withdrawn

NCT00360282Not Applicable

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?

Completed

NCT01057160Phase 4

Rizatriptan 10 MG RPD in the Treatment of Acute Migraine

Completed

NCT00397254Phase 4

Two Rizatriptan Prescribing Portions for Treatment of Migraine

Completed

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9